Select Bibliography

Filter by any of these (after searching):

Oncologist

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 16 items

Age and the Risk of Paclitaxel‐Induced Neuropathy in Women with Early‐Stage Breast Cancer (Alliance A151411): Results from 1,881 Patients from Cancer and Leukemia Group B (CALGB) 40101

Barginear, Myra , Dueck, Amylou C. , Allred, Jacob B. ... - - Oncologist - 2019

Manuscript - Primary - Primary - Older Adult - A151411 , CALGB-40101 , CALGB-70301

Older‐Patient‐Specific Cancer Trials: A Pooled Analysis of 2,277 Patients (A151715)

Dao, Dyda , Zemla, Tyler , Jatoi, Aminah , Freedman, Rachel A. ... - - Oncologist - 2019

Manuscript - Primary - Primary - Older Adult - A151715 , CALGB-49907 , CALGB-40401

Promoting Accrual of Older Patients with Cancer to Clinical Trials: An Alliance for Clinical Trials in Oncology Member Survey (A171602)

Freedman, Rachel A. , Dockter, Travis J. , Lafky, Jacqueline M. ... - - Oncologist - 2018

Manuscript - Primary - Primary - Older Adult - A171602

Cabozantinib Versus Sunitinib for Untreated Patients with Advanced Renal Cell Carcinoma of Intermediate or Poor Risk: Subgroup Analysis of the Alliance A031203 CABOSUN trial

George, Daniel J. , Hessel, Colin , Halabi, Susan ... - - Oncologist - 2019

Manuscript - Secondary - Primary - GU - A031203

A Phase II Randomized Trial of Panitumumab, Erlotinib, and Gemcitabine Versus Erlotinib and Gemcitabine in Patients with Untreated, Metastatic Pancreatic Adenocarcinoma: North Central Cancer Treatment Group Trial N064B (Alliance)

Halfdanarson, Thorvardur R. , Foster, Nathan R. , Kim, George P. ... - - Oncologist - 2019

Manuscript - Primary - Primary - GI - N064B

N064A (Alliance): Phase II Study of Panitumumab, Chemotherapy, and External Beam Radiation in Patients with Locally Advanced Pancreatic Adenocarcinoma.

Halfdanarson, Thorvardur R , Foster, Nathan R , Kim, George P ... - - Oncologist - 2022

Manuscript - Primary - Primary - GI - N064A

Tumor Status at 12 Weeks Predicts Survival in Advanced Colorectal Cancer: Findings from NCCTG N9741

Heun, James M. , Grothey, Axel , Branda, Megan E. ... - - Oncologist - 2011

Manuscript - Secondary - Primary - GI - NCCTG-N9741

Does Sunscreen Prevent Epidermal Growth Factor Receptor (EGFR) Inhibitor–Induced Rash? Results of a Placebo-Controlled Trial from the North Central Cancer Treatment Group (N05C4)

Jatoi, Aminah , Thrower, Abby , Sloan, Jeff A. , Flynn, Patrick J. ... - - Oncologist - 2010

Manuscript - Primary - Primary - Prevention - N05C4

A Study of Thymidylate Synthase Expression as a Biomarker for Resectable Colon Cancer: Alliance (Cancer and Leukemia Group B) 9581 and 89803

Niedzwiecki, Donna , Hasson, Rian M. , Lenz, Heinz‐Josef ... - - Oncologist - 2017

Manuscript - Secondary-not-in-original - Meta-Analysis - GI - C89803 , C9581

A Cancer and Leukemia Group B Phase II Study of Sunitinib Malate in Patients with Previously Treated Metastatic Pancreatic Adenocarcinoma (CALGB 80603)

O'Reilly, Eileen M. , Niedzwiecki, Donna , Hall, Margaret ... - - Oncologist - 2010

Manuscript - Primary - Primary - GI - CALGB-80603

A Phase II Study of Pazopanib in Patients with Malignant Pleural Mesothelioma: NCCTG N0623 (Alliance)

Parikh, Kaushal , Mandrekar, Sumithra J. , Allen‐Ziegler, Katie ... - - Oncologist - 2020

Manuscript - Primary - Primary - Respiratory - NCCTG-N0623

Randomized Phase II Study of Two Doses of Pixantrone in Patients with Metastatic Breast Cancer (NCCTG N1031, Alliance).

Sideras, Kostandinos , Hillman, David W , Giridhar, Karthik ... - - Oncologist - 2022

Manuscript - Primary - Primary - Breast - N1031

Relationship Between Metformin Use and Recurrence and Survival in Patients With Resected Stage III Colon Cancer Receiving Adjuvant Chemotherapy: Results From North Central Cancer Treatment Group N0147 (Alliance)

Singh, Preet Paul , Shi, Qian , Foster, Nathan R. , Grothey, Axel ... - - Oncologist - 2016

Manuscript - Secondary-not-in-original - Primary - GI - NCCTG-N0147

Phase II Study of Everolimus in Metastatic Malignant Melanoma (NCCTG‐N0377, Alliance)

Vera Aguilera, Jesus , Rao, Ravi D. , Allred, Jacob B. ... - - Oncologist - 2018

Manuscript - Primary - Primary - Experimental - N0377

Validation of Progression‐Free Survival as a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) Trials

Wang, Xiaofei , Wang, Xiaoyi , Hodgson, Lydia , George, Stephen L. ... - - Oncologist - 2017

Manuscript - Secondary-not-in-original - Primary - Respiratory - C8435 , C8638 , C8833 , C8933 , C9031 , CALGB-30101 , CALGB-30107 , CALGB-30307 , CALGB-30601 , CALGB-39807 , CALGB-9131 , CALGB-9234 , CALGB-9530 , CALGB-9631 , CALGB-9733 , N0021 , NCCTG-N0623

Expanding Beyond Maximum Grade: Chemotherapy Toxicity over Time by Age and Performance Status in Advanced Non‐Small Cell Lung Cancer in CALGB 9730 (Alliance A151729)

Wong, Melisa L. , Gao, Junheng , Thanarajasingam, Gita ... - - Oncologist - 2021

Manuscript - Primary - Primary - Older Adult - A151729 , CALGB-9730